{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T01:30:13Z","timestamp":1767922213586,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jsat.2011.12.009","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T13:17:32Z","timestamp":1328102252000},"page":"285-290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparing buprenorphine induction experience with heroin and prescription opioid users"],"prefix":"10.1016","volume":"43","author":[{"given":"Suzanne","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Hillhouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larissa","family":"Mooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2011.12.009_bb0005","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1360-0443.2001.9656834.x","article-title":"A meta-analysis comparing buprenorphine to methadone for treatment of opiate dependence","volume":"96","author":"Barnett","year":"2001","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2011.12.009_bb0010","series-title":"Beck depression inventory manual","author":"Beck","year":"1993"},{"key":"10.1016\/j.jsat.2011.12.009_bb0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.drugalcdep.2003.10.012","article-title":"Prescription opioid abuse in patients presenting for methadone maintenance treatment","volume":"73","author":"Brands","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.12.009_bb0020","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.drugalcdep.2006.09.002","article-title":"Initial evidence for the reliability and validity of a \u201clite\u201d version of the Addiction Severity Index","volume":"87","author":"Cacciola","year":"2007","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.12.009_bb0025","series-title":"Treatment Improvement Protocol (TIP) Series 40","article-title":"Clinical guidelines for the use of buprenorphine in the treatment of opioid addiction","author":"Centre for Substance Abuse Treatment","year":"2004"},{"key":"10.1016\/j.jsat.2011.12.009_bb0030","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1360-0443.1986.tb00385.x","article-title":"Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction","volume":"81","author":"Childress","year":"1986","journal-title":"British Journal of Addiction"},{"key":"10.1016\/j.jsat.2011.12.009_bb0035","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.drugalcdep.2005.05.009","article-title":"Major increases in opioid analgesic abuse in the United States: Concerns and strategies","volume":"81","author":"Compton","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.12.009_bb0040","first-page":"7","article-title":"Buprenorphine induction and stabilisation in the treatment of opiate dependence","volume":"7","author":"Doran","year":"2005","journal-title":"Heroin Addiction and Related Clinical Problems"},{"key":"10.1016\/j.jsat.2011.12.009_bb0045","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/ADM.0b013e31809b5df2","article-title":"Two-year experience with buprenorphine\u2013naloxone (suboxone) for maintenance treatment of opioid dependence within a private practice setting","volume":"1","author":"Finch","year":"2007","journal-title":"Journal of Addiction Medicine"},{"issue":"2, Suppl 1","key":"10.1016\/j.jsat.2011.12.009_bb0050","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0376-8716(03)00060-7","article-title":"Buprenorphine: How to use it right","volume":"70","author":"Johnson","year":"2003","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2011.12.009_bb0055","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11606-008-0866-8","article-title":"Home buprenorphine\/naloxone induction in primary care","volume":"24","author":"Lee","year":"2009","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2011.12.009_bb0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1360-0443.1998.9344753.x","article-title":"Buprenorphine maintenance treatment of opiate dependence: A multicenter, randomized clinical trial","volume":"93","author":"Ling","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2011.12.009_bb0065","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2011.12.009_bb0070","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00005650-199401000-00004","article-title":"The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups","volume":"32","author":"McHorney","year":"1994","journal-title":"Medical Care"},{"key":"10.1016\/j.jsat.2011.12.009_bb0075","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","article-title":"Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients","volume":"22","author":"Moore","year":"2007","journal-title":"Journal of General Internal Medicine"},{"key":"10.1016\/j.jsat.2011.12.009_bb0080","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/pds.1276","article-title":"Increasing deaths from opioid analgesics in the United States.","volume":"15","author":"Paulozzi","year":"2006","journal-title":"Pharmacoepidemiology and Drug Safety"},{"key":"10.1016\/j.jsat.2011.12.009_bb0085","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/10550490600625624","article-title":"Characterizing the emerging population of prescription opioid abusers","volume":"15","author":"Sigmon","year":"2006","journal-title":"American Journal of Addiction"},{"key":"10.1016\/j.jsat.2011.12.009_bb0090","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1017\/S146114570700836X","article-title":"Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: Results from a randomized study","volume":"11","author":"Soyka","year":"2008","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jsat.2011.12.009_bb0095","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Medicine Care"},{"key":"10.1016\/j.jsat.2011.12.009_bb0100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1521-0391.2009.00017.x","article-title":"Conducting clinical research with prescription opioid dependence: Defining the population","volume":"19","author":"Weiss","year":"2010","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2011.12.009_bb0105","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The Clinical Opiate Withdrawal Scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2011.12.009_bb0110","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jsat.2010.04.001","article-title":"Factors associated with complicated buprenorphine inductions","volume":"39","author":"Whitley","year":"2010","journal-title":"Journal of Substance Abuse Treatment"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547211002753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547211002753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:37:32Z","timestamp":1760038652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547211002753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0740547211002753"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2011.12.009","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparing buprenorphine induction experience with heroin and prescription opioid users","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2011.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}